Pretreatment fasting plasma glucose and insulin modify dietary weight loss success: results from 3 randomized clinical trials

Autor: Mads F. Hjorth, Ellen E. Blaak, Thomas Larsen, Arne Astrup, Dominique Langin, Thorkild I. A. Sørensen, Christian Ritz, Sanne Kellebjerg Poulsen, Wim H. M. Saris, Yishai Zohar
Přispěvatelé: RS: NUTRIM - HB/BW section A, RS: NUTRIM - R1 - Obesity, diabetes and cardiovascular health, RS: NUTRIM - R1 - Metabolic Syndrome
Rok vydání: 2017
Předmět:
0301 basic medicine
Blood Glucose
Dietary Fiber
Male
Medicine (miscellaneous)
PROTEIN
prediabetes
Overweight
Body Weight Maintenance
0302 clinical medicine
Weight loss
Insulin
Prediabetes
glucose
personalized nutrition
LOW-FAT DIET
Whole Grains
Nutrition and Dietetics
diabetes
Glycemic Load
LOW-CARBOHYDRATE
Middle Aged
Glycemic index
Female
medicine.symptom
fiber
Adult
medicine.medical_specialty
Diet
Reducing

precision medicine
030209 endocrinology & metabolism
03 medical and health sciences
RESISTANCE STATUS
Internal medicine
Diabetes mellitus
Glycemic load
Weight Loss
medicine
Diabetes Mellitus
Humans
Obesity
Glycemic
030109 nutrition & dietetics
business.industry
OVERWEIGHT ADULTS
weight
Feeding Behavior
medicine.disease
Endocrinology
glycemic index
LOW-GLYCEMIC LOAD
business
Energy Intake
Zdroj: American Journal of Clinical Nutrition, 106(2), 499-505. Oxford University Press
ISSN: 1938-3207
0002-9165
Popis: Background: Which diet is optimal for weight loss and maintenance remains controversial and implies that no diet fits all patients.Objective: We studied concentrations of fasting plasma glucose (FPG) and fasting insulin (FI) as prognostic markers for successful weight loss and maintenance through diets with different glycemic loads or different fiber and whole-grain content, assessed in 3 randomized trials of overweight participants.Design: After an 8-wk weight loss, participants in the DiOGenes (Diet, Obesity, and Genes) trial consumed ad libitum for 26 wk a diet with either a high or a low glycemic load. Participants in the Optimal well-being, development and health for Danish children through a healthy New Nordic Diet (OPUS) Supermarket intervention (SHOPUS) trial consumed ad libitum for 26 wk the New Nordic Diet, which is high in fiber and whole grains, or a control diet. Participants in the NUGENOB (Nutrient-Gene Interactions in Human Obesity) trial consumed a hypocaloric low-fat and high-carbohydrate or a high-fat and low-carbohydrate diet for 10 wk. On the basis of FPG before treatment, participants were categorized as normoglycemic (FPG
Databáze: OpenAIRE